Search Results 351-360 of 16802 for GLP-1 agonists

  1. Untitled

    Page 1.

  2. Neurofibromatosis type 1 - Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

  3. Role of Neuropilin-1 in Pathogenesis of Cardiovascular Diseases - Tumor Angiogenesis and Vascular Biology Laboratory - Mayo Clinic Research

    The Mukhopadhyay Tumor Angiogenesis and Vascular Biology Lab at Mayo Clinic is studying the role of neuropilin-1 in the pathogenesis of cardiovascular ...

  4. Phase 1/2 Study of AG-221 in Subjects With Advanced Hematologic Malignancies With an IDH2 Mutation - Mayo Clinic

    About this study. Study AG221-C-001 is a Phase 1/2, multicenter, open-label, dose-escalation, safety, PK/PD, and clinical activity evaluation of orally ...

  5. Clofazimine (oral route) - Side effects & dosage - Mayo Clinic

    For lepromatous leprosy (dapsone-resistant):. Adults—100 milligrams (mg) in combination with one or more other antileprosy drugs for 3 years. Your doctor may ...

  6. TransCon (TC) TLR7/​8 Agonist, TC IL-2 β/​γ, Pembrolizumab Prior to Surgery for Advanced Head and Neck Squamous Cell Carcinoma (BelieveIT-201) - Mayo Clinic

    ... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market. Study IDs. Site IRB.

  7. Efficacy and Safety of Cannabidiol for Gastroparesis and Functional Dyspepsia - Mayo Clinic

    ... 1 trial. Phase 4 trials look at long-term safety and effectiveness ... GLP-1 receptor or amylin agonists in patients with diabetes mellitus. Stable ...

  8. Lactobacillus acidophilus (oral route) - Mayo Clinic

    For oral dosage form (capsules):. For healthy stomach and intestines. Adults—1 capsule once a day. Children—Use and dose must be determined by your doctor ...

  9. Gadopiclenol (intravenous route) - Side effects & uses - Mayo Clinic

    A doctor or other trained health professional will give you or your child this medicine. This medicine is given through an IV that is placed in one of your ...

  10. A Phase 1-2 Multi-Center Study Evaluating Axicabtagene Ciloleucel in Subjects With Refractory Aggressive Non-Hodgkin Lymphoma (ZUMA-1) - Mayo Clinic

    ... agonists, 4-1BB agonists, etc). Toxicities due to prior therapy must be stable and recovered to ≤ Grade 1 (except for clinically non-significant toxicities ...